By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


European Medicines Agency 

7 Westferry Circus
Canary Wharf
London    E14 4HB  United Kingdom
Phone: 44-0-20-7523-7600 Fax: n/a



Company News
Oasmia Has Submitted A Marketing Authorization Application To The European Medicines Agency For Its Lead Cancer Product Apealea (Paclical) 2/8/2016 6:18:44 AM
Arch Biopartners Inc. Submits Orphan Drug Application For AB569 To European Medicines Agency 2/3/2016 10:36:28 AM
European Medicines Agency Validates Gilead (GILD)’s Type II Variation Application For Truvada® For Reducing The Risk Of Sexually Acquired HIV 2/1/2016 10:11:04 AM
Exelixis (EXEL) Announces European Medicines Agency Acceptance Of Marketing Authorization Application For Cabozantinib As A Treatment Foradvanced Renal Cell Carcinoma 1/29/2016 9:28:13 AM
Steba Biotech Completes Its European Phase 3 Clinical Trial Of TOOKAD In Patients With Low-Risk Prostate Cancer And Submits Marketing Authorization Application To The European Medicines Agency 1/25/2016 5:54:17 AM
Cleveland Biolabs Inc. (CBLI) Attains Orphan Drug Status From The European Medicines Agency For Entolimod As A Radiation Countermeasure 1/21/2016 11:12:41 AM
Arrowhead Research Corporation (ARWR)'s ARC-AAT Granted European Medicines Agency Orphan Drug Designation 1/19/2016 10:38:22 AM
PTC Therapeutics (PTCT) Completes Rolling NDA Submission To FDA And Submits Phase 3 ACT DMD Clinical Trial Results To European Medicines Agency for Translarna (ataluren) For Treatment Of Nonsense Mutation Duchenne Muscular Dystrophy 1/8/2016 6:23:39 AM
Cardiome Pharma Corp. (COM.TO) And SteadyMed (STDY) Announce Decision For Centralized Review Of Trevyent By The European Medicines Agency 1/6/2016 11:03:09 AM
AcelRx (ACRX) Receives Notice Of Eligibility For Centralized Review Of ARX-04 From European Medicines Agency 12/23/2015 10:20:48 AM